{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:35:40Z","timestamp":1790454940759,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0625302"],"award-info":[{"award-number":["JP24wm0625302"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJMS2021"],"award-info":[{"award-number":["JPMJMS2021"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007467","name":"Keio University School of Medicine Graduate School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007467","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15793"],"award-info":[{"award-number":["22K15793"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03001"],"award-info":[{"award-number":["22H03001"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jad.2025.04.165","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:13:28Z","timestamp":1745925208000},"page":"354-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Glutamate plus glutamine to GABA ratio as a predictor of ketamine response in treatment-resistant depression: A double-blind, randomized, open-label extension study"],"prefix":"10.1016","volume":"383","author":[{"given":"Yohei","family":"Ohtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie","family":"Nomoto-Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Yatomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sota","family":"Tomiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kusudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotaro","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.E.","family":"Edden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.04.165_bb0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpsychires.2022.04.037","article-title":"Real-world effectiveness of ketamine in treatment-resistant depression: a systematic review & meta-analysis","volume":"151","author":"Alnefeesi","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.04.165_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders (5th ed.): DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jad.2025.04.165_bb0015","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1176\/ajp.156.9.1380","article-title":"Competence of depressed patients for consent to research","volume":"156","author":"Appelbaum","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fnins.2019.00616","article-title":"Interaction of sex and age on the dissociative effects of ketamine action in young healthy participants","volume":"13","author":"Derntl","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jad.2025.04.165_bb0030","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4088\/JCP.11ac07225","article-title":"Assessing the adequacy of past antidepressant trials: a clinician\u2019s guide to the antidepressant treatment response questionnaire","volume":"72","author":"Desseilles","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0035","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tics.2015.10.007","article-title":"The neural crossroads of psychiatric illness: an emerging target for brain stimulation","volume":"20","author":"Downar","year":"2016","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.jad.2025.04.165_bb0040","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/jmri.24478","article-title":"Gannet: a batch-processing tool for the quantitative analysis of gamma-aminobutyric acid\u2013edited MR spectroscopy spectra: Gannet: GABA Analysis Toolkit","volume":"40","author":"Edden","year":"2014","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.jad.2025.04.165_bb0045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41386-018-0057-1","article-title":"7T 1H-MRS in major depressive disorder: a ketamine treatment study","volume":"43","author":"Evans","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2025.04.165_bb0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0006-3223(03)00231-2","article-title":"Diagnosis and definition of treatment-resistant depression","volume":"53","author":"Fava","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0055","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41380-018-0256-5","article-title":"Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)","volume":"25","author":"Fava","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0060","series-title":"Structured Clinical Interview for DSM-5\u2014Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV)","author":"First","year":"2015"},{"issue":"2","key":"10.1016\/j.jad.2025.04.165_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","article-title":"Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression","volume":"17","author":"Haile","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.04.165_bb0070","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.2022.21506","article-title":"Adjustment for baseline characteristics in randomized clinical trials","volume":"328","author":"Holmberg","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2025.04.165_bb0075","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/s41380-023-02193-x","article-title":"Brain-wide changes in excitation-inhibition balance of major depressive disorder: a systematic review of topographic patterns of GABA- and glutamatergic alterations","volume":"28","author":"Hu","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jad.2018.09.037","article-title":"Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial","volume":"243","author":"Ionescu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.04.165_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neurobiolaging.2004.07.001","article-title":"Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T","volume":"26","author":"Kaiser","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.jad.2025.04.165_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JCP.0b013e31802eb4b7","article-title":"Why do clinical trials fail? The problem of measurement error in clinical trials: time to test new paradigms?","volume":"27","author":"Kobak","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.04.165_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1099800418776082","article-title":"Biological sex differences in depression: a systematic review","volume":"20","author":"Labaka","year":"2018","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.jad.2025.04.165_bb0105","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.biopsych.2016.05.005","article-title":"Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine","volume":"81","author":"Lener","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0110","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s44220-023-00140-x","article-title":"Randomized trial of ketamine masked by surgical anesthesia in patients with depression","volume":"1","author":"Lii","year":"2023","journal-title":"Nat. Ment. Health"},{"key":"10.1016\/j.jad.2025.04.165_bb0115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neubiorev.2011.05.014","article-title":"Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings","volume":"36","author":"Luykx","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.04.165_bb0120","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1002\/hbm.24201","article-title":"Age-related differences in GABA levels are driven by bulk tissue changes","volume":"39","author":"Maes","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2025.04.165_bb0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jad.2020.07.045","article-title":"Burden of Treatment Resistant Depression (TRD) in patients with major depressive disorder in Ontario using Institute for Clinical Evaluative Sciences (ICES) databases: economic burden and healthcare resource utilization","volume":"277","author":"McIntyre","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.04.165_bb0130","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2215-0366(23)00183-9","article-title":"Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies","volume":"10","author":"Medeiros","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0135","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J","article-title":"Simultaneous in vivo spectral editing and water suppression","volume":"11","author":"Mescher","year":"1998","journal-title":"NMR Biomed."},{"key":"10.1016\/j.jad.2025.04.165_bb0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/mp.2015.83","article-title":"A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder","volume":"21","author":"Milak","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13211","article-title":"Assessment of relationship of ketamine dose with magnetic resonance spectroscopy of Glx and GABA responses in adults with major depression: a randomized clinical trial","volume":"3","author":"Milak","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2025.04.165_bb0150","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-006-0409-0","article-title":"Greater vulnerability to the amnestic effects of ketamine in males","volume":"187","author":"Morgan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.04.165_bb0155","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/s41380-018-0252-9","article-title":"Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies","volume":"24","author":"Moriguchi","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","article-title":"Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA","volume":"86","author":"Mullins","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2025.04.165_bb0165","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/s41380-022-01730-4","article-title":"Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial","volume":"27","author":"Narayan","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0170","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109357","article-title":"Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory\/inhibitory synaptic activity","volume":"225","author":"Nguyen","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2025.04.165_bb0180","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.4088\/JCP.13m08698","article-title":"Clinical predictors of ketamine response in treatment-resistant major depression","volume":"75","author":"Niciu","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/pcn.13734","article-title":"Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial","author":"Ohtani","year":"2024","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.04.165_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2023.115113","article-title":"A comprehensive guide to MEGA-PRESS for GABA measurement","volume":"669","author":"Peek","year":"2023","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jad.2025.04.165_bb0195","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1038\/s41380-022-01757-7","article-title":"International pooled patient-level meta-analysis of ketamine infusion for depression: in search of clinical moderators","volume":"27","author":"Price","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0200","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jad.2021.12.090","article-title":"Health-related quality of life burden associated with treatment-resistant depression in UK patients: quantitative results from a mixed-methods non-interventional study","volume":"300","author":"Rathod","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.04.165_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118191","article-title":"No balance between glutamate+glutamine and GABA+ in visual or motor cortices of the human brain: a magnetic resonance spectroscopy study","volume":"237","author":"Rideaux","year":"2021","journal-title":"Neuroimage"},{"key":"10.1016\/j.jad.2025.04.165_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.04.165_bb0215","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1073\/pnas.90.12.5662","article-title":"Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo","volume":"90","author":"Rothman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2025.04.165_bb0220","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jad.2020.07.089","article-title":"Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: a retrospective chart review","volume":"276","author":"Sakurai","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.04.165_bb0225","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1017\/S1461145711001593","article-title":"An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression","volume":"15","author":"Salvadore","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.04.165_bb0230","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/hbm.23244","article-title":"Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies","volume":"37","author":"Sch\u00fcr","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jad.2025.04.165_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.113953","article-title":"A preliminary study of the association of increased anterior cingulate gamma-aminobutyric acid with remission of depression after ketamine administration","volume":"301","author":"Singh","year":"2021","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.04.165_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2021.111432","article-title":"Racemic ketamine treatment attenuates anterior cingulate cortex GABA deficits among remitters in treatment-resistant depression: a pilot study","volume":"320","author":"Singh","year":"2022","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"10.1016\/j.jad.2025.04.165_bb0245","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41380-019-0426-0","article-title":"Excitation-inhibition balance as a framework for investigating mechanisms in neuropsychiatric disorders","volume":"24","author":"Sohal","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105683","article-title":"Effects of sex hormones on brain GABA and glutamate levels in a cis- and transgender cohort","volume":"138","author":"Spurny-Dworak","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2025.04.165_bb0255","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/brain\/awac361","article-title":"Large-scale lesion symptom mapping of depression identifies brain regions for risk and resilience","volume":"146","author":"Trapp","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jad.2025.04.165_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.pscychresns.2010.10.009","article-title":"The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS","volume":"191","author":"Valentine","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.04.165_bb0265","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the Yale psychiatric hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0270","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/a-2179-8884","article-title":"Factors associated with antidepressant effects of ketamine: a reanalysis of double-blind randomized placebo-controlled trial of intravenous ketamine for treatment-resistant depression","volume":"57","author":"Yonezawa","year":"2024","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0275","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.04.165_bb0280","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725007505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725007505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:16:31Z","timestamp":1778300191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725007505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":56,"alternative-id":["S0165032725007505"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.04.165","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamate plus glutamine to GABA ratio as a predictor of ketamine response in treatment-resistant depression: A double-blind, randomized, open-label extension study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.04.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}